SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABIOMED --an under valued small co.
ABMD 381.020.0%Jan 3 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Capevet who wrote ()5/18/1997 5:54:00 PM
From: Robert J. Donovan   of 11
 
By far, at least as far as I'm concerned, the most important and potentially profitable product Abiomed has to offer is the total implantable artificial heart.

However, I'm not certain if the artificial heart will resolve the rejection problem, or present other problems, such as lethal blood clots.

If rejection and blood clots can be resolved, the artificial heart may someday be better than a natural donor heart. Do you agree?

Do you have any information on these aspects of Abiomed's total implantable artificial heart program?

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext